sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has revealed details of its interest in Mural Oncology plc, complying with Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure is pertinent to parties possessing interests of 1% or greater in relevant securities. The latest data available is as of July 3, 2025.
The Vanguard Group controls 772,819 ordinary shares, representing a 4.48% stake in Mural Oncology. There have been no dealings involving cash or stock-settled derivatives. However, a small sale of 16 ordinary shares at $2.58 per unit was reported. There are no reported indemnities, agreements, options, or derivative arrangements related to this holding.
No additional parties or transactions were disclosed, and a Supplemental Form 8 is not attached to this document.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.